Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...

For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a ...

The common diabetes drug metformin works partly by excreting sugar from the bloodstream into the intestines, where gut ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

This study provides valuable guidance for doctors and patients when choosing diabetes medications. It confirms that ...

Insulin resistance in T1D is more common than you think, and without early intervention, these patients face increased risks ...

A recent discovery reveals a novel physiological phenomenon linking the gut microbiome to sugar metabolism, potentially ...

Besides controlling blood sugar, Metformin has other health benefits. One of the biggest is that it helps lower the risk of ...

For millennia, humans have had an unwritten trade deal with the microbes that inhabit our guts. We feed them fiber, and they ...